News

Opening of Biotech Training Facility Leiden with Minister Kamp

- Minister Kamp at the opening the Biotech Training Facility Leiden.

Medtech Mission Germany

- Van 12 t/m 14 april 2016 organiseert de Rijksdienst voor Ondernemend Nederland, het ministerie van Buitenlandse Zaken en het postennetwerk in Duitsland i.s.m. de Task Force Health Care en FME een Medische Technologie missie naar Zuid-Duitsland voor de Nederlandse starters, kennisinstellingen en ondernemers.

ERA HDHL Cofunded Call Biomarkers in Nutrition and Health

- The JPI HDHL -together with the European Commission - is going to launch a new joint transnational call for research proposals: "Biomarkers for Nutrition and Health (BioNH)“ using the ERA-NET Cofund instrument.

Health~Holland Year in Review 2015

- We are pleased to publish the Health~Holland Year in Review 2015, our yearly magazine that brings you the developments from Top Sector Life Sciences & Health in 2015.

Polyganics Receives 510,000 euros Clearance for Nerve Capping Device

- Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve repair, neurosurgery, general surgery, as well as ear, nose & throat surgery, announced it has received FDA 510,000 euros clearance for NEUROCAP, an innovative device designed to reduce painful neuroma formation and thereby facilitate tissue repair and regeneration.

Top Team member Hans Schikan wins Roland Lageveen Award

- Tweejaarlijkse Award voor een persoon of organisatie die een uitzonderlijke bijdrage leverde aan het succes van de Nederlandse biotech sector.

#1 Healthcare in Europe according to the EHCI Report

- The Dutch receive the best care in Europe states the Euro Health Consumer Index 2015 report, released beginning of 2016.

Mimetas and Partners Receive 1.6 Million Dollar Industry Funding for Development of Organ-On-A-Chip Neurotoxicity Models

- Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim of the project is to improve existing neurotoxicity tests and to reduce experimentation on animals.

Agendia and Partners Receive $6.8 million from European Commission to Study Targeted Therapies for Colorectal Cancer

- Agendia, Inc. and several European partners have received a $6.8 million European Commission grant to study targeted therapies for colorectal cancer (CRC). The grantees will test therapies matched to the molecular subtype of each patient’s tumor, to see if they are more effective than current therapies not keyed to a tumor’s subtype.

AstraZeneca enhances long-term growth through Oncology investment in Acerta Pharma

- Acerta Pharma has entered into a definitive agreement with AstraZeneca whereby AstraZeneca will acquire a majority stake in Acerta.